Image

Addiction Potential of Very Low Nicotine Filtered Little Cigars

Addiction Potential of Very Low Nicotine Filtered Little Cigars

Recruiting
21-75 years
All
Phase 4

Powered by AI

Overview

The goal of this clinical trial is to learn how reducing the nicotine content in filtered little cigars can affect the the use of these cigars and lung health in current adult filtered little cigar users. The main question[s] it aims to answer are:

Are puffing behaviors, appeal/satisfaction, craving suppression, pharmacokinetic effects, and demand similar between the regular cigars smoked by participants, normal nicotine study cigars and very low nicotine study cigars? Are health effects and toxicant exposure similar between the regular cigars smoked by participants, normal nicotine study cigars and very low nicotine study cigars?

Participants will attend three study visits at OSU. Each visit would last up to 4 hours. During visits, they will

  • fill several surveys
  • provide blood samples
  • perform breathing tests
  • complete smoking sessions using either their own cigars or the study cigars.

Eligibility

Inclusion Criteria:

  • Smokers: 1) self-reported regular current filtered little cigars, cigarillos, little cigars, or small cigars use for the past 3 months; regular use will be defined as >=8 cigars smoked per month based on data showing median cigarillo use is 7.5 times per month and median FLC use is 14 times per month 59. We will attempt to bring in heavier users if feasible during recruitment; or 2) Dual-users: cigarette smokers (>=20d/month for at least 3 months) with co-use of filtered little cigars, cigarillos, little cigars, or small cigars (at least once in the past 3 months)
  • willing to abstain from all tobacco and nicotine for at least 12 hours prior to lab sessions
  • Willing to bring their own, preferred brand little cigars/ small cigars/ cigarillos/ filtered little cigars to smoke in the lab on the first study visit
  • capable of and willing to provide written informed consent
  • read and speak in English.

Exclusion Criteria:

  • Self-reported significant current lung disease (e.g. asthma, COPD, cystic fibrosis, pulmonary fibrosis); exercise-induced asthma, seasonal allergies for which a patient takes inhalers are allowed
  • History of diagnosis or treatment for lung cancer
  • Self-reported serious or uncontrolled kidney disease, liver disease, metabolic disease (thyroid, diabetes)
  • History of cardiac event or distress within the past 3 months
  • Unstable or significant psychiatric conditions (past and stable conditions will be allowed)
  • Substance use disorders besides nicotine addiction
  • Regular use of other tobacco products besides cigarettes such as snuff, chewing tobacco, snus, e-cigarettes >10d per month
  • Exclusive large or premium cigar users
  • Zero use of filtered little cigars, cigarillos, little cigars, or small cigars in the past 3 months
  • Use of blunts every time or most of the time
  • Regular use of cannabis >10d per month
  • Planning to quit in next 30 days or currently trying to quit or quit attempt in past 30 days
  • Pregnant, delivery in past 12 weeks, breastfeeding, or planning to get pregnant
  • Inability to perform tests or follow instructions during testing

Study details
    Smoking (Tobacco) Addiction

NCT06630728

Ohio State University Comprehensive Cancer Center

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.